Bayer seeks US FDA approval for estradiol-based oral contraceptive to treat heavy menstrual bleeding
Thursday, July 09, 2009 09:00 IST Berlin
Bayer has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for a new estradiol-based oral contraceptive (estradiol valerate/dienogest).
